Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1952 1
1954 1
1962 1
1967 1
1968 1
1969 2
1970 1
1971 1
1972 1
1978 4
1981 5
1982 3
1983 9
1984 13
1985 7
1986 7
1987 14
1988 3
1989 5
1990 12
1991 13
1992 5
1993 11
1994 6
1995 10
1996 6
1997 6
1998 8
1999 12
2000 6
2001 7
2002 8
2003 17
2004 19
2005 13
2006 17
2007 57
2008 47
2009 43
2010 41
2011 25
2012 23
2013 30
2014 27
2015 30
2016 32
2017 26
2018 38
2019 28
2020 38
2021 35
2022 33
2023 31
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

743 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. Among authors: petrini m. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Gini G, Tani M, Tucci A, Marcheselli L, Cesaretti M, Bellei M, Pascarella A, Ballerini F, Petrini M, Merli F, Olivieri A, Lanza F, Annibali O, Zilioli VR, Liberati AM, Tisi MC, Arcari A, Marino D, Musuraca G, Pavone V, Fabbri A, Pozzi S, Mannina D, Plenteda C, Celli M, Luminari S. Gini G, et al. Among authors: petrini m. Blood. 2023 Oct 26;142(17):1438-1447. doi: 10.1182/blood.2022019173. Blood. 2023. PMID: 37418685 Clinical Trial.
The Renewal of Cancer Immunotherapy.
Bulgarelli J, Pignatta S, Petrini M, Ridolfi L. Bulgarelli J, et al. Among authors: petrini m. Vaccines (Basel). 2023 Mar 4;11(3):592. doi: 10.3390/vaccines11030592. Vaccines (Basel). 2023. PMID: 36992176 Free PMC article.
Piezoelectric Signals in Vascularized Bone Regeneration.
D'Alessandro D, Ricci C, Milazzo M, Strangis G, Forli F, Buda G, Petrini M, Berrettini S, Uddin MJ, Danti S, Parchi P. D'Alessandro D, et al. Among authors: petrini m. Biomolecules. 2021 Nov 20;11(11):1731. doi: 10.3390/biom11111731. Biomolecules. 2021. PMID: 34827729 Free PMC article. Review.
Editorial: In Search of In vivo MSC.
Pacini S, Petrini M. Pacini S, et al. Among authors: petrini m. Front Cell Dev Biol. 2017 May 29;5:60. doi: 10.3389/fcell.2017.00060. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 28611984 Free PMC article. No abstract available.
Lithium in the treatment of neutropenia.
Petrini M, Azzarà A. Petrini M, et al. Curr Opin Hematol. 2012 Jan;19(1):52-7. doi: 10.1097/MOH.0b013e32834da93b. Curr Opin Hematol. 2012. PMID: 22123660 Retracted. Review.
Mitigation, resilience, and nursing.
Petrini MA. Petrini MA. Nurs Health Sci. 2014 Mar;16(1):1-2. doi: 10.1111/nhs.12132. Nurs Health Sci. 2014. PMID: 24635894 No abstract available.
743 results